Author/Authors :
Nokhodian، Zary نويسنده Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan , , Meshkati، Marjan نويسنده Isfahan Province Health Center,Isfahan University of Medical Sciences, Isfahan , , Adibi، Peyman نويسنده , , Ataei، Behrooz نويسنده Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan , , Kassaian، Nazila نويسنده Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan , , Yaran، Majid نويسنده Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran , , Shoaei، Parisa نويسنده Infectious Diseases and Tropical Medicine Research center, Isfahan University of Medical Sciences, Isfahan , , Hassannejad، Razieh نويسنده Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan ,
Abstract :
Objectives: Hepatitis C virus (HCV) is one of the major public health
problems worldwide which is transmitted through contact with infected
blood or blood products. One of the most prevalent modes of
HCV transmission is injecting drug with unclean needles or syringes.
Therefore intravenous drug users (IVDUs) are the most important
group who should be considered. The aim of this study was to evaluate
seroprevalence and risk factors of hepatitis C virus in IVDUs population.
Methods: The cross-sectional study was carried out on intravenous
drug users who attended health and social care Drop-in centers during
November 2008 to February 2009 in Isfahan province, Iran. Data was
gathered using interviewer-administered questionnaire including demographic
characteristics and main risk factors for HCV infection. 5ml
venous blood sample was obtained from each subject. The HCV-Ab
test was performed on all blood samples by ELISA. The data was analyzed
using descriptive statistical methods and multiple logistic regressions
by SPSS software, version 15.
Results: The mean age of participants was 31.77 ± 8.51. 503 (94.7%)
were men and 28 (5.3%) were women. HCV seroprevalence was 47.1%
(95% CI: 42.9, 51.3). The multiple logistic regressions demonstrated
that history of tattooing (OR 1.72, 95% CI 1.02-2.90), history of imprisonment
(OR 2.49, 95% CI 1.40-4.42) and sharing needles/syringes
(OR 2.76, 95% CI 1.54-4.95) are significant predictors of risk of HCV
in IVDU population.
Conclusions: In conclusion, according to the high prevalence of HCV
infection among IVDUs and high adds of HCV infection from tattooing,
sharing of needles/syringes and imprisonment, effective harm
reduction programs should be expanded among IVDUs to prevent
new HCV infections.